Federated Hermes Inc. Has $14.34 Million Stock Position in Avantor, Inc. (NYSE:AVTR)

Federated Hermes Inc. lifted its holdings in Avantor, Inc. (NYSE:AVTR - Free Report) by 19.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 628,189 shares of the company's stock after purchasing an additional 104,296 shares during the period. Federated Hermes Inc. owned 0.09% of Avantor worth $14,342,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. DAVENPORT & Co LLC increased its stake in Avantor by 126.6% during the third quarter. DAVENPORT & Co LLC now owns 1,941,315 shares of the company's stock valued at $40,641,000 after acquiring an additional 1,084,567 shares during the period. Park Place Capital Corp increased its stake in Avantor by 18.2% during the third quarter. Park Place Capital Corp now owns 3,039 shares of the company's stock valued at $64,000 after acquiring an additional 467 shares during the period. Norris Perne & French LLP MI increased its stake in Avantor by 0.5% during the third quarter. Norris Perne & French LLP MI now owns 464,986 shares of the company's stock valued at $9,802,000 after acquiring an additional 2,493 shares during the period. Asset Management One Co. Ltd. increased its stake in Avantor by 1.7% during the third quarter. Asset Management One Co. Ltd. now owns 264,144 shares of the company's stock valued at $5,568,000 after acquiring an additional 4,349 shares during the period. Finally, Handelsbanken Fonder AB increased its stake in Avantor by 169.5% during the third quarter. Handelsbanken Fonder AB now owns 131,716 shares of the company's stock valued at $2,777,000 after acquiring an additional 82,843 shares during the period. 95.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP James Bramwell sold 6,203 shares of the company's stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the completion of the transaction, the executive vice president now directly owns 101,143 shares of the company's stock, valued at approximately $2,476,992.07. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 1.30% of the company's stock.

Avantor Stock Up 5.1 %

NYSE AVTR traded up $1.25 on Tuesday, reaching $25.66. The company had a trading volume of 5,608,711 shares, compared to its average volume of 5,695,338. The firm has a market capitalization of $17.40 billion, a price-to-earnings ratio of 53.45, a price-to-earnings-growth ratio of 2.45 and a beta of 1.37. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.05 and a current ratio of 1.61. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $26.16. The company's fifty day moving average is $25.03 and its 200-day moving average is $22.55.

Avantor (NYSE:AVTR - Get Free Report) last announced its earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping analysts' consensus estimates of $0.22 by $0.03. The firm had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.70 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The company's revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.32 EPS. On average, research analysts forecast that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on AVTR shares. Raymond James lifted their price objective on Avantor from $22.50 to $26.00 and gave the company an "outperform" rating in a report on Friday, January 26th. Royal Bank of Canada lifted their price objective on Avantor from $28.00 to $29.00 and gave the company an "outperform" rating in a report on Thursday, February 15th. Barclays lifted their price objective on Avantor from $27.00 to $30.00 and gave the company an "overweight" rating in a report on Wednesday, April 10th. UBS Group lifted their price objective on Avantor from $25.00 to $29.00 and gave the company a "buy" rating in a report on Thursday, February 15th. Finally, Robert W. Baird lifted their price objective on Avantor from $25.00 to $26.00 and gave the company an "outperform" rating in a report on Thursday, February 15th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $26.71.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.